Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 7Colonic Neoplasms 6Recurrence 4Prostatic Neoplasms 4Neoplasms 4Polycythemia Vera 3Venous Thromboembolism 2Thrombocythemia, Essential 2Rectal Neoplasms 2Myocardial Infarction 2Esophageal Neoplasms 2Cardiovascular Diseases 2Adenoma 2Vascular Diseases 1Thrombosis 1Thrombocytopenia 1Stomach Neoplasms 1Primary Myelofibrosis 1Precancerous Conditions 1Pathologic Processes 1Node Positive HER2 Negative Breast Cancer 1Neoplasms by Site 1Neoplasm Metastasis 1Myocardial Ischemia 1Myeloproliferative Disorders 1Multiple Myeloma 1Lynch syndrome I (site-specific colonic cancer) 1Lymphoma, Follicular 1Liver Cirrhosis 1Ischemic Stroke 1

Interventions

Fulvestrant 2ribociclib 1duvelisib 1Secretin 1Rituximab 1NVP-BKM120 1Letrozole 1Everolimus 1CA-19-9 Antigen 1Aspirin 1Alpelisib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Hereditary Sensory and Autonomic Neuropathies × Aspirin × Clear all
NCT02467582 2025-05-16

Adjuvant Aspirin Treatment for Colon Cancer Patients

Swiss Cancer Institute

Phase 3 Terminated
1,040 enrolled 11 charts
Gastrointestinal

Colonic Neoplasms, Hereditary Sensory and Autonomic Neuropathies

Data powered by HemOnc (CC BY 4.0) Colophon âš¡